JP2009538344A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538344A5
JP2009538344A5 JP2009512301A JP2009512301A JP2009538344A5 JP 2009538344 A5 JP2009538344 A5 JP 2009538344A5 JP 2009512301 A JP2009512301 A JP 2009512301A JP 2009512301 A JP2009512301 A JP 2009512301A JP 2009538344 A5 JP2009538344 A5 JP 2009538344A5
Authority
JP
Japan
Prior art keywords
intracellularis
animal
vaccinated
antigen
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009512301A
Other languages
English (en)
Japanese (ja)
Other versions
JP5257901B2 (ja
JP2009538344A (ja
Filing date
Publication date
Priority claimed from US11/750,458 external-priority patent/US8470336B2/en
Application filed filed Critical
Publication of JP2009538344A publication Critical patent/JP2009538344A/ja
Publication of JP2009538344A5 publication Critical patent/JP2009538344A5/ja
Application granted granted Critical
Publication of JP5257901B2 publication Critical patent/JP5257901B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009512301A 2006-05-25 2007-05-24 ローソニア・イントラセルラリス感染に対する幼若動物のワクチン接種 Active JP5257901B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80320706P 2006-05-25 2006-05-25
US60/803,207 2006-05-25
US11/750,458 2007-05-18
US11/750,458 US8470336B2 (en) 2006-05-25 2007-05-18 Vaccination of young animals against Lawsonia intracellularis infections
PCT/US2007/069646 WO2007140244A2 (en) 2006-05-25 2007-05-24 Vaccination of young animals against lawsonia intracellularis infections

Publications (3)

Publication Number Publication Date
JP2009538344A JP2009538344A (ja) 2009-11-05
JP2009538344A5 true JP2009538344A5 (enExample) 2010-07-15
JP5257901B2 JP5257901B2 (ja) 2013-08-07

Family

ID=38779345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009512301A Active JP5257901B2 (ja) 2006-05-25 2007-05-24 ローソニア・イントラセルラリス感染に対する幼若動物のワクチン接種

Country Status (9)

Country Link
US (1) US8470336B2 (enExample)
EP (1) EP2029166A4 (enExample)
JP (1) JP5257901B2 (enExample)
KR (2) KR20090018838A (enExample)
CN (1) CN103394080A (enExample)
AU (1) AU2007267574B2 (enExample)
CA (1) CA2652049C (enExample)
MX (1) MX2008014882A (enExample)
WO (1) WO2007140244A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2200643B1 (en) * 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌(Lawsonia intracellularis)用疫苗
ES2534556T3 (es) * 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US10265392B2 (en) * 2015-02-04 2019-04-23 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479430A (en) 1967-08-24 1969-11-18 Diamond Lab Inc Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same
US3907987A (en) 1972-05-25 1975-09-23 Canadian Patents Dev Enteric disease vaccine
US4132597A (en) 1976-06-09 1979-01-02 Ab Medipharm Method for cultivation of bacteria
US4237218A (en) 1979-02-09 1980-12-02 Bio-Rad Laboratories, Inc. Micro-carrier cell culture
NL8102786A (nl) * 1981-06-10 1983-01-03 Duphar Int Res Werkwijze voor het immuniseren van varkens tegen de ziekte van aujeszky.
JPS5991879A (ja) 1982-11-16 1984-05-26 Hideaki Yamada シユ−ドモナス属細菌の培養法
DK594084A (da) 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
JPH0644865B2 (ja) 1985-10-29 1994-06-15 三菱瓦斯化学株式会社 カンピロバクタ−属細菌の培養方法
JPS62198627A (ja) * 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk オ−エスキ−病可溶化抗原ワクチン
US5338670A (en) 1986-07-28 1994-08-16 The United States Of America As Represented By The Department Of Health And Human Services Production of bordetella pertussis toxin with a low concentration of iron
IT1227657B (it) 1988-12-01 1991-04-23 Mini Ricerca Scient Tecnolog Antibiotici ab-021 e processo per la loro produzione
JPH0822221B2 (ja) 1988-12-28 1996-03-06 日東化学工業株式会社 シュードモナス属細菌の培養法
JPH02308754A (ja) 1989-05-24 1990-12-21 Yakult Honsha Co Ltd 乳発酵食品の製造法
US5296221A (en) 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
US5192679A (en) 1990-05-03 1993-03-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Growing ehrlichia species in a continuous cell line
EP0555366B1 (en) 1990-11-01 2000-06-28 Iowa State University Research Foundation, Inc. Bacterial attenuation method and vaccine
DE4208785A1 (de) 1992-03-19 1993-09-23 Degussa Verfahren zum auffinden von insertionselementen (is-elemente) oder transposonen
DK0839050T3 (da) 1992-09-28 2004-10-25 Wyeth Corp Fremgangsmåde til at forstærke celleformidlede immunreaktioner
US5610059A (en) 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
JP2000502054A (ja) 1995-11-30 2000-02-22 アグリカルチャー ビクトリア サービシーズ ピーティーワイ.エルティーディー. 治療用および診断用の組成物
US7052697B1 (en) 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
US20030157120A1 (en) 1999-05-13 2003-08-21 Michael Panaccio Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
EP1094070A3 (en) * 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
AU784344B2 (en) * 2000-01-28 2006-03-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions
CN1443076A (zh) 2000-05-24 2003-09-17 梅瑞尔公司 猪生殖和呼吸综合症病毒(prrsv)重组禽痘病毒疫苗
MY128159A (en) 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
JP2004529854A (ja) 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
US20020103261A1 (en) 2000-10-06 2002-08-01 Dusan Ninkov Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
DE60144201D1 (de) 2000-12-20 2011-04-21 Intervet Int Bv Lawsonia intracellularis Impfstoff
US20030087421A1 (en) 2001-07-11 2003-05-08 Gebhart Connie J Lawsonia intracellularis
EP1570045A4 (en) 2002-10-04 2007-09-05 Univ Minnesota NUCLEIC ACID AND POLYPEPTIDE SEQUENCES FROM LAWSONIA INTRACELLULARIS AND METHOD OF USE
UA87665C2 (ru) 2003-07-25 2009-08-10 Берингер Ингельхайм Ветмедика, Инк. Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
CN1849334A (zh) 2003-09-12 2006-10-18 阿克佐诺贝尔公司 胞内劳森氏菌亚单位疫苗
BRPI0507017A (pt) 2004-01-22 2007-06-05 Intervet Int Bv ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico
US7550270B2 (en) 2004-08-13 2009-06-23 Boehringer Ingelheim Vetmedica, Inc. Ileitis diagnostic assay
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US20090215698A1 (en) 2005-04-18 2009-08-27 Boehringer Ingelheim Vetmedica, Inc. Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
JP2009509496A (ja) 2005-04-28 2009-03-12 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド ローソニアイントラセルラリスの免疫学的タンパク
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
EP3320919B1 (en) 2005-12-29 2020-05-27 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2200643B1 (en) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
US8142760B2 (en) 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis

Similar Documents

Publication Publication Date Title
Sharun et al. Advances in therapeutic and managemental approaches of bovine mastitis: a comprehensive review
JP2009538344A5 (enExample)
Albernaz-Gonçalves et al. Linking animal welfare and antibiotic use in pig farming—a review
Ismail et al. Feed-based vaccination regime against streptococcosis in red tilapia, Oreochromis niloticus x Oreochromis mossambicus
Vosloo et al. Natural habitats in which foot-and-mouth disease virus is maintained
Leitner et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial
Villumsen et al. Oral and anal vaccination confers full protection against enteric redmouth disease (ERM) in rainbow trout
UA103298C2 (ru) Способ лечения молодых свиней с помощью антигена pcv2
Schoos et al. Use of non‐steroidal anti‐inflammatory drugs in porcine health management
Chomel Diseases transmitted by less common house pets
RU2008105348A (ru) Вакцина на основе lawsonia и способы ее применения
TWI328458B (en) Subunit vaccine of pasteurella multocida in veterinary uses
JP2022513337A (ja) 動物の腸管感染症及び急性下痢を治療する組成物及び方法
Van der Fels-Klerx et al. Effects on productivity and risk factors of Bovine Respiratory Disease in dairy heifers; a review for the Netherlands
Saad et al. Necessary usage of antibiotics in animals
Chao et al. Different rabies outbreaks on two beef cattle farms in the same province of China: Diagnosis, virus characterization and epidemiological analysis
Kyriakis et al. Field Study on the Efficacy of Two Different Vaccination Schedules with HYORESP® in a Mycoplasma hyopneumoniae‐Infected Commercial Pig Unit
Awa et al. Livestock pathology in the central African region: some epidemiological considerations and control strategies
CN102307898A (zh) 用以蛋白质交联和固定剂固定作为抗原的微生物制造包罗性抗表面抗体的方法
Mohamed et al. Effect of administration of ultra-corn with bivalent Foot and Mouth disease oil vaccine in calves
WO2007059360A2 (en) Oral use of specific antibodies for intestinal health
JP2012158562A (ja) 鯉の新型穴あき病の予防方法
Mustaffa et al. Comprehensive review on prevalence of caseous lymphadenitis (CLA) in dairy goats: A systematic review and meta-analysis: https://doi. org/10.12982/VIS. 2025.074
RU2792118C1 (ru) Способ лечения респираторно-синцитиальной инфекции крупного рогатого скота
Pozzi et al. Clinical description of an outbreak of foot and mouth disease in a pig close-cycle unit